Speaker Profile
Ph.D., Inventor, MammaPrint; Professor of Laboratory Medicine, Dir. Applied Genomics, UCSF
Biography
Dr. van t Veer is a worldrenowned molecular biologist whose research focuses on precision medicine to advance patient management based on knowledge of the genetic makeup of the tumor and the patient. As inventor of MammaPrint she has made seminal impact on rightsizing the treatment of breast cancer and on molecular genomics. Dr. van t Veer is Biomarker Committee Chair for the multicenter clinical trial ISPY 2, overseeing the processes for FDAIDE biomarker usage and qualifying biomarker companion diagnostics. She has over 330 peerreviewed scientific articles and is coinventor of 6 patents. Dr. van t Veer received the 2007 ESMO lifetime achievement award and the prestigious European Union Women Innovator Award, 2nd prize in 2014. Dr. van t Veer earned her PhD in Medicine at the University of Leiden as well as two postdoctoral fellowships, at the Cancer Center of Harvard Medical School and Mass General Hospital followed at The Netherlands Cancer Institute.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Laura J. van 't Veer, UCSF
- PMWC 2024 Award Ceremony
Pioneer Honoree: David Sidransky, Johns Hopkins
Luminary Honorees: Helmy Eltoukhy & AmirAli Talasaz, Guardant Health - Utilities of Liquid Biopsy in Biomarker Testing
- Laura Vent Veer, UCSF - Status Quo of Clinical Liquid Biopsy
Chair: Helmy Eltoukhy, Guardant Health
- Sadakatsu Ikeda, Tokyo Medical University
- Heather Parsons, Dana-Farber Cancer Institute
- Bruna Pellini, Moffitt Cancer Center
- Sanjay Popat, The Royal Marsden - Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
Chair: Anne-Renee Hartman, Adela Bio
- AmirAli Talasaz, Guardant Health
- Heather Parsons, Dana-Farber Cancer Institute
- Mary Pat Lancelotta, Adaptive Bio - Liquid Biopsy in Early Cancer Detection (PANEL)
Chair: Tom Beer, Exact Sciences
- Wendy Rubinstein, Cancer Screening Research Network (CSRN) - Keynote: Pioneering Liquid Nucleic acids Tumor Fragments in Health and Diseases
- David Sidransky, Johns Hopkins - New Approaches in Liquid Biopsy (PANEL)
Chair: Victor Velculescu, Johns Hopkins
- David Sidransky, Johns Hopkins
- Dan Laudau, NY Genome Center
- Daniel De Carvalho, University of Toronto - Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
Chair: Debra Fraser-Howze, D. Fraser Associates
- Belinda Nedjai, Wolfson Institute of Population Health
- Elisabeth Adams, Aquarius Population Health Limited - PMWC Showcase
- Sandrine Miller-Montgomery, Micronoma
